Polycythemia Vera News and Research

RSS
Personalized determination of genetic factors may improve treatment for polycythaemia vera

Personalized determination of genetic factors may improve treatment for polycythaemia vera

Ruxolitinib shows promise in severe COVID-19

Ruxolitinib shows promise in severe COVID-19

Popular cancer drug linked to weight gain and increased systolic blood pressure

Popular cancer drug linked to weight gain and increased systolic blood pressure

Study: More than 300 million people affected worldwide by rare diseases

Study: More than 300 million people affected worldwide by rare diseases

FDA approves new drug to treat patients with myelofibrosis

FDA approves new drug to treat patients with myelofibrosis

People who have a parent, sibling, or child with blood cancer have higher risk of disease

People who have a parent, sibling, or child with blood cancer have higher risk of disease

Potential combination therapy against rare disease of the bone marrow could improve treatment

Potential combination therapy against rare disease of the bone marrow could improve treatment

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Detailed structure of protein pair offers blueprint for new medicines

Detailed structure of protein pair offers blueprint for new medicines

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

Study finds new therapeutic target to prevent progression of rare blood cancer

Study finds new therapeutic target to prevent progression of rare blood cancer

New NCCN Guidelines outline diagnosis, treatment strategies for myeloproliferative neoplasms

New NCCN Guidelines outline diagnosis, treatment strategies for myeloproliferative neoplasms

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Minihepcidins may potentially treat serious genetic blood diseases in children, adults

Penn study forms basis for new treatment approaches for Sezary syndrome

Penn study forms basis for new treatment approaches for Sezary syndrome

Three researchers recognised for their contributions to Australian medical research

Three researchers recognised for their contributions to Australian medical research

Novartis to highlight strength of its expanded oncology portfolio at ASCO 2015

Novartis to highlight strength of its expanded oncology portfolio at ASCO 2015

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Positive results from pacritinib Phase 3 trial for treatment of myelofibrosis presented at ASCO 2015

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Data from pacritinib Phase 3 PERSIST-1 trial in patients with myelofibrosis to be highlighted at ASCO

Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

Johns Hopkins scientists use genome editing technology to alter human stem cells

Johns Hopkins scientists use genome editing technology to alter human stem cells